New international study evaluates the AO Spine–DGOU osteoporotic fracture score for treatment decision-making

The AO Spine Knowledge Forum Trauma and Infection has initiated a major international multicenter study designed to evaluate the clinical utility of the osteoporotic fracture (OF) classification-based scoring system in thoracolumbar fractures associated with primary osteoporosis.

Led by the AO Spine Knowledge Forum Trauma and Infection, the TL-OF study (The osteoporotic fracture classification-based scoring system for treatment decision in thoracolumbar osteoporotic fractures: An international multicenter prospective study) represents one of the most comprehensive prospective investigations in this patient population to date.

Addressing a growing clinical challenge

Osteoporotic thoracolumbar vertebral fractures represent a rapidly increasing global healthcare burden, driven largely by aging populations. Principal Investigator Klaus Schnake highlighted, that despite their prevalence, treatment decision-making remains complex. “Surgeons frequently face uncertainty when choosing between surgical and nonsurgical management, particularly in patients with symptomatic fractures where mobility, pain, and quality of life are substantially affected.”

The OF classification and scoring system was developed to provide a structured, evidence-informed framework for fracture assessment and treatment guidance. While the scoring system has shown favorable clinical short-term clinical results in a national study in Germany, prospective international validation in real-world clinical practice is  limited. The TL-OF study directly addresses this gap.

Co-Principal Investigator Sebastian Bigdon said the primary objective of the study is to determine whether adherence to the OF score system leads to improved short-term outcomes. “Specifically, investigators aim to assess whether an initial treatment decision aligned with the OF score recommendations result in a faster return to the patient’s pre-injury or pre-symptom mobility level at three months following treatment.”

Co-Principal Investigator Ratko Yurac further explained that the underlying hypothesis is straightforward yet clinically meaningful: “In symptomatic osteoporotic thoracolumbar fractures, adherence to the OF Score recommendations will result in a faster return of mobility at three months compared with treatment decisions that do not adhere to the score.”

International efforts to improve patient outcomes globally

Fifteen international sites across Europe, North and South America, Asia, and the Middle East are participating in the study to ensure the outcomes are truly global in alignment with the mandate of the Knowledge Forums.

Through a rigorous process, the AO Innovation Translation Center, Clinical Evidence team, and Network Clinical Research collaborate to select broad international collaboration, with participating centers located in Brazil, Chile, Egypt, Finland, Argentina, Germany, India, Japan, Malaysia, Romania, Saudi Arabia, Switzerland, the United Kingdom, and the United States.

This global distribution enhances the external validity of the findings and ensures representation of diverse healthcare systems, clinical practices, and patient populations.

The AO Spine Knowledge Forum Trauma and Infection has initiated a major international multicenter study designed to evaluate the clinical utility of the osteoporotic fracture (OF) classification-based scoring system in thoracolumbar fractures associated with primary osteoporosis.

Led by the AO Spine Knowledge Forum Trauma and Infection, the TL-OF study (The osteoporotic fracture classification-based scoring system for treatment decision in thoracolumbar osteoporotic fractures: An international multicenter prospective study) represents one of the most comprehensive prospective investigations in this patient population to date.

Addressing a growing clinical challenge

Osteoporotic thoracolumbar vertebral fractures represent a rapidly increasing global healthcare burden, driven largely by aging populations. Principal Investigator Klaus Schnake highlighted, that despite their prevalence, treatment decision-making remains complex. “Surgeons frequently face uncertainty when choosing between surgical and nonsurgical management, particularly in patients with symptomatic fractures where mobility, pain, and quality of life are substantially affected.”

The OF classification and scoring system was developed to provide a structured, evidence-informed framework for fracture assessment and treatment guidance. While the scoring system has shown favorable clinical short-term clinical results in a national study in Germany, prospective international validation in real-world clinical practice is  limited. The TL-OF study directly addresses this gap.

Co-Principal Investigator Sebastian Bigdon said the primary objective of the study is to determine whether adherence to the OF score system leads to improved short-term outcomes. “Specifically, investigators aim to assess whether an initial treatment decision aligned with the OF score recommendations result in a faster return to the patient’s pre-injury or pre-symptom mobility level at three months following treatment.”

Co-Principal Investigator Ratko Yurac further explained that the underlying hypothesis is straightforward yet clinically meaningful: “In symptomatic osteoporotic thoracolumbar fractures, adherence to the OF Score recommendations will result in a faster return of mobility at three months compared with treatment decisions that do not adhere to the score.”

International efforts to improve patient outcomes globally

Fifteen international sites across Europe, North and South America, Asia, and the Middle East are participating in the study to ensure the outcomes are truly global in alignment with the mandate of the Knowledge Forums.

Through a rigorous process, the AO Innovation Translation Center, Clinical Evidence team, and Network Clinical Research collaborate to select broad international collaboration, with participating centers located in Brazil, Chile, Egypt, Finland, Argentina, Germany, India, Japan, Malaysia, Romania, Saudi Arabia, Switzerland, the United Kingdom, and the United States.

This global distribution enhances the external validity of the findings and ensures representation of diverse healthcare systems, clinical practices, and patient populations.